⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001830908

Dyer Timothy Mark

Reports to the SEC for 1 company · GENEVA

Transactions

4

Companies

1

Filings

1

CIK

0001830908

Forms 4 and 5

Insider transactions

4 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-02	ADXNAddex Therapeutics Ltd.D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−16.4M sh	—	—	435,192
2026-09-02	ADXNAddex Therapeutics Ltd.A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+16.4M sh	—	—	16,848,979
2026-09-02	ADXNAddex Therapeutics Ltd. · Stock-option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−3.37M sh	—	—	0
2026-09-02	ADXNAddex Therapeutics Ltd. · Stock-option (Right to Buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+3.37M sh	—	—	3,369,796

Recent filings

1

Accepted (ET)
Sep 44
Dyer Timothy Mark0001104659-26-105481
SEC(opens sec.gov)

Companies

1

Addex Therapeutics Ltd.Director, CHIEF EXECUTIVE OFFICERADXN

Address

CHEMIN DES MINES 9

GENEVA, CH-1202